|
ADSS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20869999956186E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09479999998996E-06 |
| Normal-vs-Stage2 |
2.134600E-01 |
| Normal-vs-Stage3 |
2.550800E-04 |
| Normal-vs-Stage4 |
4.956500E-04 |
| Stage1-vs-Stage2 |
9.742100E-02 |
| Stage1-vs-Stage3 |
9.677400E-01 |
| Stage1-vs-Stage4 |
4.431200E-01 |
| Stage2-vs-Stage3 |
1.409780E-01 |
| Stage2-vs-Stage4 |
5.914300E-02 |
| Stage3-vs-Stage4 |
4.757800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.30729999953716E-07 |
| Normal-vs-AfricanAmerican |
5.316300E-03 |
| Normal-vs-Asian |
9.359200E-04 |
| Caucasian-vs-AfricanAmerican |
4.015600E-01 |
| Caucasian-vs-Asian |
3.798000E-01 |
| AfricanAmerican-vs-Asian |
8.878000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.763200E-04 |
| Normal-vs-Female |
4.00779999965017E-07 |
| Male-vs-Female |
9.218000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.1325000000334E-07 |
| Normal-vs-Age(41-60Yrs) |
2.152800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.794300E-04 |
| Normal-vs-Age(81-100Yrs) |
7.440800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.237760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.370000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.730980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.170400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.272800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.768800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.667000E-01 |
| Classical-VS-Follicular |
2.22199999511119E-08 |
| Classical-VS-Other |
4.299600E-01 |
| Classical-VS-Normal |
6.44549968953356E-10 |
| Tall-VS-Follicular |
6.010200E-04 |
| Tall-VS-Other |
3.258000E-01 |
| Tall-VS-Normal |
2.35669999999466E-05 |
| Follicular-VS-Other |
3.104000E-01 |
| Follicular-VS-Normal |
9.828000E-01 |
| Other-VS-Normal |
1.403950E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.008220E-02 |
| Normal-vs-N1 |
2.499200E-03 |
| N0-vs-N1 |
8.793700E-02 |
|
|
